Immunex Corporation
Lymphokines for therapeutic use as anti-cancer agents supporting the human immune system
- Year invested 1992
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Company Status IPO/Public (by Amgen)
Lymphokines for therapeutic use as anti-cancer agents supporting the human immune system